MBHB Partner Kevin Noonan Quoted In Article Entitled, “Allergan Use of Tribe’s Sovereignty Called Risk to Patent System”

McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. is quoted in a June 4, 2018 Bloomberg article entitled, “Allergan Use of Tribe’s Sovereignty Called Risk to Patent System.” Technology companies, banks and insurers say that allowing drugmaker Allergan Plc to use an American Indian tribe’s sovereign immunity to avoid competition from generics could undercut a system to weed out bad patents. View the articlestyle=”WIDTH: 1469px; DISPLAY: block”>